Clinical Trial Update: Effects of Sage on Memory and Mental Performance in Alzheimer's Disease Patients [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Sage (Salvia officinalis) for memory and mental performance in Alzheimer's disease patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Sage (Salvia officinalis)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED